tiprankstipranks
Trending News
More News >
Iradimed Corp (IRMD)
NASDAQ:IRMD
US Market

Iradimed (IRMD) Technical Analysis

Compare
155 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Iradimed Corp’s (IRMD) Moving Averages Convergence Divergence (MACD) indicator is 1.89, suggesting Iradimed Corp is a Sell.
Iradimed Corp’s (IRMD) 20-Day exponential moving average is 55.54, while Iradimed Corp’s (IRMD) share price is $60.5, making it a Buy.
Iradimed Corp’s (IRMD) 50-Day exponential moving average is 54.06, while Iradimed Corp’s (IRMD) share price is $60.5, making it a Buy.

Iradimed (IRMD) Pivot Points

Jun 07, 2025, 02:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
58.03
58.91
59.85
60.73
61.67
62.55
63.49
Fibonacci
58.91
59.61
60.04
60.73
61.43
61.86
62.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Iradimed (IRMD) Moving Averages

Jun 07, 2025, 02:49 PM
Period
Simple
Exponential
MA5
59.32Buy
59.13Buy
MA10
56.23Buy
57.36Buy
MA20
54.58Buy
55.54Buy
MA50
52.98Buy
54.06Buy
MA100
54.57Buy
53.56Buy
MA200
52.70Buy
51.57Buy
Iradimed Corp’s (IRMD) 10-Day exponential moving average is 57.36, while Iradimed Corp’s (IRMD) share price is $60.5, making it a Buy.
Iradimed Corp’s (IRMD) 100-Day exponential moving average is 53.56, while Iradimed Corp’s (IRMD) share price is $60.5, making it a Buy.
Iradimed Corp’s (IRMD) stock price is $60.5 and Iradimed Corp’s (IRMD) 50-day simple moving average is 52.98, creating a Buy signal.
Iradimed Corp’s (IRMD) stock price is $60.5 and Iradimed Corp’s (IRMD) 100-day simple moving average is 54.57, creating a Buy signal.
Iradimed Corp’s (IRMD) stock price is $60.5 and Iradimed Corp’s (IRMD) 200-day simple moving average is 52.70, creating a Buy signal.

Iradimed (IRMD) Technical Indicators

Jun 07, 2025, 02:49 PM
Name
Value
Implied Action
RSI (14)
69.02
Neutral
STOCH (9,6)
92.24
Sell
STOCHRSI (14)
92.24
Sell
MACD (12,26)
1.89
Sell
ADX (14)
21.18
Neutral
Williams %R
-11.73
Sell
CCI (14)
161.32
Sell
ATR (14)
2.16
-
Ultimate Oscillator
67.41
Neutral
ROC
12.42
Buy
Iradimed Corp’s (IRMD) Relative Strength Index (RSI) is 69.02, creating a Neutral signal.
Iradimed Corp’s (IRMD) Trend Strength Indicator (ADX) is 21.18, creating a Neutral signal.
Iradimed Corp’s (IRMD) Commodity Channel Index (CCI) is 161.32, creating a Sell signal.
Iradimed Corp’s (IRMD) Price Rate of Change (ROC) is 12.42, creating a Buy signal.

FAQ

Is IRMD a Buy, Hold, or Sell?
Based on IRMD’s technical indicators, IRMD is a Buy.
    What is IRMD’s RSI (14)?
    IRMD’s RSI (14) is 69.02, which suggests IRMD is a Neutral.
      What is IRMD’s MACD?
      IRMD’s MACD is 1.89, which suggests IRMD is a Sell.
        What is IRMD’s 5-day moving average?
        IRMD’s 5-day moving average is 59.32, which suggests IRMD is a Buy.
          What is IRMD’s 20-day moving average?
          IRMD 20-day moving average is 54.58, which suggests IRMD is a Buy.
            What is IRMD’s 50-day moving average?
            IRMD’s 50-day moving average is 52.98, which suggests IRMD is a Buy.
              What is IRMD’s 200-day moving average?
              IRMD’s 200-day moving average is 52.70, which suggests IRMD is a Buy.
                What is IRMD’s Williams % R (14)?
                IRMD’s Williams % R (14) is -11.73, which suggests IRMD is a Sell.
                  What is IRMD’s CCI (14)?
                  IRMD’s CCI (14) is 161.32, which suggests IRMD is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis